Private American academic medical center focused on integrated healthcare, education, and research.
The FDA has approved daraxonrasib, sold as Rasonque by Revolution Medicines, for adults with previously treated or ineligible metastatic pancreatic cancer. Clinical trials have shown median survival extended to about 13.2 months versus roughly 6.7 months with chemotherapy. The drug will be available in the US with a roughly $39,800 monthly list price and expanded-access programmes have already treated thousands.
Major US medical societies have issued unified guidance this week for flu, COVID-19 and RSV vaccines after the CDC’s advisory process has been disrupted. Updated COVID shots have FDA approval and manufacturers are shipping doses, but legal and policy disputes over federal recommendations continue to leave states and insurers uncertain about timing and coverage.
Investors have pushed new biotech winners — from Novo Nordisk’s semaglutide pill to startups tackling baldness and targeted autoimmune drugs — while market enthusiasm has cooled for some forecasts. Novo Nordisk has released a daily weight‑loss pill used by over 1.5 million people; hair‑loss startups have sent small caps soaring; India’s low‑cost GLP‑1 generics have underperformed expectations.
A UK study involving nearly 1 million adults has found that drinking beverages at very hot temperatures is associated with a higher risk of esophageal squamous cell carcinoma (SCC). The risk rises with frequency, but overall numbers remain small. Experts urge cooling drinks before consumption and maintaining other protective habits.
Saphier has been nominated to serve as surgeon general. She is navigating questions about vaccine policy, credentials, and potential conflicts of interest as lawmakers scrutinize her readiness to lead public health messaging.
White House Chief of Staff Susie Wiles has announced she is cancer-free, six months after revealing an early-stage breast cancer diagnosis. She thanked supporters and said she will continue to advance the Trump administration's agenda.
Walmart has expanded benefits for associates, adding 12 weeks of neonatal ICU leave and enabling second opinions for rare conditions. It also joins Novo and Lilly drug coverage for Type 2 diabetics at no cost, while premium increases are minimized. The moves come ahead of open enrollment and build on years of compensation improvements.